Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573660 · ClinicalTrials.gov registry record
Abbott Vascular Medical Device Registry
A clinical trial of Acute Myocardial Infarction and Venous Embolism, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 3,784
- Enrollment target
- 20
- Study locations
NCT04573660: Recruiting study of Acute Myocardial Infarction and Venous Embolism, sponsored by Abbott Medical Devices.
NCT04573660 is a study of Acute Myocardial Infarction and Venous Embolism that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 3,784 participants, above the 1,683-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (125% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04573660, a study of Acute Myocardial Infarction and Venous Embolism, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 3,784 participants
- Enrollment target
- 20
- Study locations
Study Summary
The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expected lifetime, ensuring the continued acceptability of identified risks, detecting emerging risks on the basis of factual evidence, ensuring the continued acceptability of the benefit-risk ratio, and identifying possible systematic misuse or off-label usage such that the intended use can be verified as appropriate.
Primary Outcome
Composite of all-cause death, MI or target lesion revascularization (TLR) will be assessed among the patients who receive Coronary Stents.
Conditions Studied
Interventions
- DEVICE Coronary and peripheral stents
- DEVICE Pacing catheters
- DEVICE Vascular plugs
- DEVICE Measurement and imaging (FFR and OCT)
- DEVICE Peripheral dilatation catheters
Study Locations (20)
WAUS
- Perth Institute of Vascular Research - Nedlands
- Sir Charles Gairdner Hospital - Nedlands
Eflndrs
- Onze-Lieve-Vrouwziekenhuis Campus Aalst - Aalst
- AZ Sint-Blasius Ziekenhuis - Dendermonde
Zhejian
- Jinhua Municipal Central Hospital - Jinhua
- Ningbo First Hospital - Ningbo
Alabama
- University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham
Arkansas
- Arkansas Heart Hospital - Little Rock
California
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
Illinois
- Northwestern Memorial Hospital - Chicago
Nebraska
- Bryan Heart - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,784 participants |
| Start Date | 2020-10-25 |
| Est. Completion | 2031-11 |
What NCT04573660 shows while recruiting
NCT04573660 is an observational study that tracks outcomes without assigning an intervention. Its 3,784 participants enrollment target places it among the larger protocols in the corpus, above the 1,683-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (125% higher).
The record links to 5 conditions, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 5 interventions - of which Coronary and peripheral stents is the first listed.
NCT04573660 names 20 study sites across 17 states, led by WAUS, Eflndrs, Zhejian.
Frequently Asked Questions
What is clinical trial NCT04573660 about?
NCT04573660 is a clinical study titled "Abbott Vascular Medical Device Registry". The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expec...
What is the current status of trial NCT04573660?
This trial is currently recruiting. The enrollment target is 3,784 participants. The study started on 2020-10-25. Estimated completion is 2031-11.
What conditions does trial NCT04573660 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction, Venous Embolism, Restenoses, Coronary, Coronary Artery Lesions, Arterial Embolism.
What interventions are being tested in trial NCT04573660?
The interventions under investigation include: Coronary and peripheral stents (DEVICE), Pacing catheters (DEVICE), Vascular plugs (DEVICE), Measurement and imaging (FFR and OCT) (DEVICE), Peripheral dilatation catheters (DEVICE).
Who is sponsoring clinical trial NCT04573660?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04573660 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04573660's enrollment target sits among peer trials
3,784 4th of 19 higher than 16 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
-
Molecular and Morphologic Characterization of Circulating Endothelial Cells
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI